Abstract
Background The most popular method for measuring upper limb activity is based on accelerometery. However, this method is prone to overestimation and is agnostic to the functional utility of a movement. In this study, we used an inertial measurement unit(IMU)-based gross movement score to quantify arm-use in hemiparetic patients at home.
Objectives (i) Validate the gross movement score detected by wrist-worn IMUs against functional movements identified by human assessors. (ii) Test the feasibility of using wrist-worn IMUs to measure arm-use in patients’ natural settings.
Methods To validate the gross movement score two independent assessors analyzed and annotated the video recordings of 5 hemiparetic patients and 10 healthy controls performing a set of activities while wearing IMUs. The second study tracked arm-use of 5 hemiparetic patients and 5 healthy controls using two wrist-worn IMUs for 7 days and 3 days, respectively. The IMU data obtained from this study was used to develop quantitative measures (total and relative arm-use (RAU)) and a visualization method for arm-use.
Results The gross movement score detects functional movement with 50–60% accuracy in hemiparetic patients, and is robust to non-functional movements. Healthy controls showed a slight bias towards the dominant arm (RAU: 40.52º). Patients’ RAU varied between 15–47º depending upon their impairment level and pre-stroke hand dominance.
Conclusions The gross movement score performs moderately well in detecting functional movements while rejecting non-functional movements. The patients’ total arm-use is less than healthy controls, and their relative arm-use is skewed towards the less-impaired arm.
Clinical trial registry number CTRI/2018/09/015648
Competing Interest Statement
Dr Varadhan SKM has a financial interest in Kriya Neurotechnologies Private Limited, a company that makes IMU-based Neurorehabilitation devices. The study was not funded by the company. The company had no role in the study design, data collection, or analysis. All other authors declare that there is no conflict of interest.
Clinical Trial
CTRI/2018/09/015648
Funding Statement
The authors disclosed receipt of the following financial support for the research of this article: This work was supported by the Fluid Research Grant from CMC Vellore. (grant number: IRB Min No 11303).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The institutional review board of Christian Medical College Vellore, India approved this study.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data are available on request to authors.
